Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (2019)
Mcmurray, J. J. V; Solomon, S. D; Inzucchi, S. E; Kober, L; Kosiborod, M. N; Martinez, F. A; Ponikowski, P; Sabatine, M. S; Anand, I. S; Nicolau, José Carlos 
Source: New england journal of medicine. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, PROTEÍNAS DE TRANSPORTE, RESULTADO DE TRATAMENTO, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCMURRAY, J. J. V et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New england journal of medicine, v. 381, n. 21, p. 1995-2008, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1911303. Acesso em: 13 nov. 2024.APA
Mcmurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Kober, L., Kosiborod, M. N., Martinez, F. A., et al. (2019). Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New england journal of medicine, 381( 21), 1995-2008. doi:10.1056/NEJMoa1911303NLM
Mcmurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Nicolau JC. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction [Internet]. New england journal of medicine. 2019 ; 381( 21): 1995-2008.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1056/NEJMoa1911303Vancouver
Mcmurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Nicolau JC. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction [Internet]. New england journal of medicine. 2019 ; 381( 21): 1995-2008.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1056/NEJMoa1911303
